M. Lutz

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease

A D Roses, E M Reiman, A. Roses, 2009, The Pharmacogenomics Journal.

Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?

I. Deary, M. Bastin, J. Starr, 2014, Translational Psychiatry.

Lyall, D.M. et al. (2014) Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter

I. Deary, J. Starr, M. Bastin, 2014 .

Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms

I. James, F. Mastaglia, A. Saunders, 2013, Neuromuscular Disorders.

Using Genetics to Enable Studies on the Prevention of Alzheimer's Disease

A. Roses, K. Welsh-Bohmer, S. Brannan, 2013, Clinical pharmacology and therapeutics.

Study of “ALS reversals”: LifeTime environmental exposures (StARLiTE)

R. Bedlack, P. Mehta, M. Lutz, 2022, Amyotrophic lateral sclerosis & frontotemporal degeneration.